<!DOCTYPE html>
<html lang="en">

<head>
  <title>Acute Coronary Syndromes | The Peripheral Brain</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <script src='https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.2/MathJax.js?config=TeX-MML-AM_CHTML'></script>

  <link rel="stylesheet" href="/peripheral_brain/css/main.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/mobile.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/buttons.css" />

  
    <link rel="stylesheet" href="/peripheral_brain/css/diseases.css">
  


  <link href="https://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Slab" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Mono" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Condensed" rel="stylesheet">


  <link rel="apple-touch-icon" sizes="180x180" href="/peripheral_brain/favicons/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/peripheral_brain/favicons/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/peripheral_brain/favicons/favicon-16x16.png">
  <link rel="manifest" href="/peripheral_brain/favicons/site.webmanifest">
  <link rel="mask-icon" href="/peripheral_brain/favicons/safari-pinned-tab.svg" color="#465c8b">
  <link rel="shortcut icon" href="/peripheral_brain/favicons/favicon.ico">
  <meta name="apple-mobile-web-app-title" content="Peripheral Brain">
  <meta name="application-name" content="Peripheral Brain">
  <meta name="msapplication-TileColor" content="#da532c">
  <meta name="msapplication-config" content="/peripheral_brain/favicons/browserconfig.xml">
  <meta name="theme-color" content="#cdcdcd">


  

</head>


<body class="body">
<header id="myHeader" class="myHeader">
  <nav>
    <!-- <a href="/peripheral_brain/home.html"><img src="/peripheral_brain/images/logo_1000x1000.png" alt="Logo"> -->
    <a href="/peripheral_brain/home.html">Home</a>
    <a href="/peripheral_brain/disease_list.html">Diseases and Drugs</a>
    <a href="/peripheral_brain/firstFive">TF5M</a>
    <a href="/peripheral_brain/lab_values">Lab Values</a>
    <a href="/peripheral_brain/formulas">Formulas</a>
    <a href="/peripheral_brain/calculators.html">Calculators</a>
    <a href="/peripheral_brain/search.html">Search</a>
    <a href="javascript:void(0);" class="icon" onclick="openMenu()">&#9776;</a>
  </nav>

  <script>
  function openMenu() {
      var x = document.getElementById("myHeader");
      if (x.className === "myHeader") {
          x.className += " responsive";
      } else {
          x.className = "myHeader";
      }
  }
  </script>
</header>


<h1 class="title">Acute Coronary Syndromes</h1>

<div class="contents twoCol">
  <div class="toc col1">
    
      <ul>
  <li><a href="#ua-vs-nstemi-vs-stemi">UA vs NSTEMI vs STEMI</a>
    <ul>
      <li><a href="#shared-exam-findings">Shared Exam Findings</a></li>
    </ul>
  </li>
  <li><a href="#universal-management-of-acs">Universal Management of ACS</a>
    <ul>
      <li><a href="#mona-therapy">MONA Therapy</a></li>
    </ul>
  </li>
  <li><a href="#stemi">STEMI</a>
    <ul>
      <li><a href="#pci-managment">PCI Managment</a></li>
      <li><a href="#medical-managment">Medical Managment</a></li>
      <li><a href="#secondary-prevention">Secondary Prevention</a></li>
    </ul>
  </li>
  <li><a href="#nstemi">NSTEMI</a>
    <ul>
      <li><a href="#ischemia-strategy-vs-early-invasive">Ischemia Strategy vs Early Invasive</a></li>
      <li><a href="#timi-risk-score-for-nste-acs">TIMI Risk Score for NSTE-ACS</a></li>
      <li><a href="#ischemia-guided-therapy">Ischemia Guided Therapy</a></li>
      <li><a href="#early-invasive-therapy">Early Invasive Therapy</a></li>
    </ul>
  </li>
  <li><a href="#guidelines">Guidelines</a></li>
</ul>

    
  </div>

  <div class="content col2">
    <h1 id="ua-vs-nstemi-vs-stemi">UA vs NSTEMI vs STEMI</h1>

<table>
  <thead>
    <tr>
      <th> </th>
      <th>UA</th>
      <th>NSTEMI</th>
      <th>STEMI</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Pain Duration</td>
      <td>Rest, &gt;20 min</td>
      <td>Rest, &gt;20 min</td>
      <td>Rest, &gt;20 min</td>
    </tr>
    <tr>
      <td>Pain Relieved by NTG</td>
      <td>Maybe</td>
      <td>No</td>
      <td>No</td>
    </tr>
    <tr>
      <td>ST Elevation</td>
      <td>No</td>
      <td>No</td>
      <td>Yes</td>
    </tr>
    <tr>
      <td>Q Waves Present</td>
      <td>No</td>
      <td>Uncommon</td>
      <td>Yes</td>
    </tr>
    <tr>
      <td>Troponin</td>
      <td>Negative</td>
      <td>Positive</td>
      <td>Positive</td>
    </tr>
  </tbody>
</table>

<h2 id="shared-exam-findings">Shared Exam Findings</h2>

<ul>
  <li>SSx of Ventricular Dysfunction</li>
  <li>Variable HR</li>
  <li>Elevated RR</li>
  <li>Abnormal Heart Sounds</li>
</ul>

<h1 id="universal-management-of-acs">Universal Management of ACS</h1>

<h2 id="mona-therapy">MONA Therapy</h2>

<ol>
  <li>Morphine 2-4mg IV q5-30min in increments of 2-8mg PRN
    <ul>
      <li>BP and RR after each bolus</li>
      <li>Can consider meperidine or other opiod</li>
      <li>D/C all NSAIDs and avoid all NSAIDs during admission</li>
    </ul>
  </li>
  <li>O<sub>2</sub> to sat of 95% if &lt; 90% on presentation</li>
  <li>SL NTG 0.4mg q5min x3, if non-responsive start IV NTG 5-10mcg/min to 75-100mcg/min (Max 200, consider 1-2min bolus of 400mcg/min to load)
    <ul>
      <li><strong>Verify NO PDEIs w/i 24-36hr</strong></li>
      <li>IV Contraindicated w/ SBP &lt; 90; &gt; 30 mmHg change from baseline; Bradycardia or Tachycardia; <strong>Suspected RV Infarction</strong></li>
      <li>Monitor BP and HR q2h while on IV</li>
    </ul>
  </li>
  <li>ASA 325mg Chewed and Swallowed on presentation</li>
  <li>Consider anxiolytics to decrease HR and demand</li>
  <li>Consider Stool Softeners: Constipation and straining w/ BM can lead to subsequent MI</li>
</ol>

<h1 id="stemi">STEMI</h1>

<p>If PCI is available w/i 90min at facility, or the pt can be transferred to a PCI facility w/i 120min, initiate PCI</p>

<h2 id="pci-managment">PCI Managment</h2>

<ol>
  <li>PCI w/i 90min</li>
  <li>DAPT w/ ASA and Clopidogrel, Ticagrelor, or Prasugrel +/- GPIs
    <ul>
      <li>Consider GPIs if Other antiplatelets are not used or during bailout for thrombotic complications</li>
    </ul>
  </li>
  <li>Anticoagulate w/  UFH or IV Bivalirudin</li>
</ol>

<h3 id="dosing">Dosing</h3>

<h4 id="antiplatelets">Antiplatelets</h4>

<ul>
  <li>ASA
    <ul>
      <li>325mg chewed and swallowed (MONA)</li>
      <li>81mg QD forever</li>
    </ul>
  </li>
  <li>Clopidogrel
    <ul>
      <li>600mg before PCI then 75mg QD for at least 1yr</li>
      <li>D/C 5d before elective CABG</li>
      <li>D/C 24hr before emergent CABG</li>
    </ul>
  </li>
  <li>Ticagrelor
    <ul>
      <li>180mg before PCI then 90mg BID for at least 12mo</li>
      <li><strong>No more than 100mg ASA QD</strong></li>
      <li>D/C 5d before elective CABG</li>
      <li>D/C 24hr before emergent CABG</li>
      <li><strong>Contraindicated in Hx of Hemorrhagic Stroke, Ischemic Stroke, PO Anticoagulant Use, Mod-Severe Liver Disease</strong></li>
      <li>Reversible inhibitor, so effects are gone 12hr after D/C</li>
    </ul>
  </li>
  <li>Prasugrel
    <ul>
      <li>60mg PO load then 10mg QD (5mg if ≤ 60kg) for at least 12mo</li>
      <li>D/C 7d before elective CABG</li>
      <li>Extreme caution in pts ≥ 75yo or ≤ 60kg</li>
      <li><strong>Contraindicated in Hx of Hemorrhagic Stroke, Ischemic Stroke, PO Anticoagulant Use, Mod-Severe Liver Disease</strong></li>
    </ul>
  </li>
  <li>Cangrelor
    <ul>
      <li>30mcg/kg IVPB then 4mcg/kg/min for 2hr or duration of PCI (whichever is longer)</li>
      <li>Higher bleeding risk than Clopidogrel</li>
      <li>Not for use w/ PO P2Y12 Inhibitors or GPI</li>
    </ul>
  </li>
</ul>

<h4 id="gpis">GPIs</h4>

<ul>
  <li>Abciximab
    <ul>
      <li>0.25 <strong>mg</strong>/kg bolus then 0.125 <strong>mcg</strong>/kg.min (Max 10) for up to 12hr after PCI</li>
    </ul>
  </li>
  <li>Eptifibitide
    <ul>
      <li>180 mcg/kg/min IV bolus q10min x2 then 2 mcg/kg/min for up to 18hr after PCI</li>
      <li>1 mcg/kg/min if CrCl &lt; 50 mL/min</li>
    </ul>
  </li>
  <li>Tirofiban
    <ul>
      <li>25 mcg/kg bolus then 0.15 mcg/kg/min for up to 18hr after PCI</li>
      <li>Reduce infusion by 50% if CrCl &lt; 30 mL/min</li>
    </ul>
  </li>
</ul>

<p>Contraindications</p>

<ul>
  <li>Active Internal Bleed, major surgery, stroke &lt; 30d</li>
  <li>Hx of Hemorrhagic Stroke</li>
  <li>Intracranial Neoplasm</li>
  <li>AV Malformation</li>
  <li>Acute PEricarditis</li>
  <li>SBP &gt; 180 or DBP &gt; 110</li>
  <li>Plt &lt; 100k</li>
</ul>

<p>Monitoring</p>

<ul>
  <li>SSx of Hemorrhage</li>
  <li>CBC: Baseline and QD</li>
  <li>SCr: Baseline and QD</li>
  <li>Plt: Baseline, 2-4hr post initiation, and QD</li>
</ul>

<h4 id="anticoagulation">Anticoagulation</h4>

<p><strong>Do not continue after procedure w/o other indication</strong></p>

<ul>
  <li>UFH
    <ul>
      <li>50-70 U/kg w/ GPI (ACT 250-350s)</li>
      <li>70-100 U/kg w/o GPI (ACT 200-250s)</li>
    </ul>
  </li>
  <li>Enoxaparin
    <ul>
      <li>0.5 mg/kg IVPB</li>
    </ul>
  </li>
  <li>Bivalirudin
    <ul>
      <li>0.75 mg/kg IVPB then 1.75 mg/kg/hr until end of PCI, can continue at 0.25 mg/kg/hr if needed</li>
      <li>No mortality advantage, but lower bleed risk and higher stent thrombosis risk</li>
      <li>Use if high risk of bleed or HIT</li>
      <li>Monitor SSx of bleeding; Baseline and QD SCr and CBC; Baseline aPTT, INR, and Plt</li>
    </ul>
  </li>
</ul>

<h3 id="antiplatelet-selection">Antiplatelet Selection</h3>

<ul>
  <li>High CV Risk Pts: Prasugrel or Ticagrelor</li>
  <li>Unknown Coronary Anatomy or High Likelihood of CABG: Ticagrelor</li>
  <li>&lt; 60kg, ≥ 75yo, or Hx of TIA: Avoid Prasugrel</li>
  <li>High Bleed Risk: Clopidogrel</li>
</ul>

<h2 id="medical-managment">Medical Managment</h2>

<ol>
  <li>Fibrinolysis w/i 30min (hopefully w/i 12hr of pain onset)</li>
  <li>DAPT w/ ASA and Clopidogrel</li>
  <li>Anticoagulate w/ UFH, IV and SC Enoxaparin, or IV and SC Fondaparinux</li>
</ol>

<h3 id="dosing-1">Dosing</h3>

<h4 id="fibrinolytics">Fibrinolytics</h4>

<ul>
  <li>SK
    <ul>
      <li>1.5million U in 50mL D5W or NS over 60min</li>
      <li>Can cause allergic reactions, hypotension, hemostatic defects, and intracerebral bleeds</li>
      <li>Do not give to a person more than once in their life</li>
      <li><strong>Can only use UFH as anticoagulant, start 3-4hr after beginning of SK</strong></li>
    </ul>
  </li>
  <li>tPA
    <ul>
      <li>15mg bolus then 0.75mg/kg (Max 50mg) over 30min then 0.5 mg/kg (Max 35mg) over 60min</li>
      <li>Hemostatic Defect and Intracerebral bleeds</li>
    </ul>
  </li>
  <li>Reteplase
    <ul>
      <li>10 U IVPB then 10 U IVPB 30min later</li>
      <li>Hemostatic Defect and Intracerebral bleeds</li>
    </ul>
  </li>
  <li>Tenecteplase
    <ul>
      <li>≤ 60kg: 30mg IVPB</li>
      <li>60-69.9kg: 35mg IVPB</li>
      <li>70-79.9kg: 40mg IVPB</li>
      <li>80-89.9kg: 45mg IVPB</li>
      <li>≥ 90kg: 50mg IVPB</li>
      <li>Hemostatic Defect and Intracerebral bleeds</li>
    </ul>
  </li>
  <li>Absolute CIs
    <ul>
      <li>Hx of Intracranial Hemorrhage</li>
      <li>Structural Cerebral Vascular Lesion</li>
      <li>Malignant IC Neoplasm</li>
      <li>Ischemic Stroke w/i 3mo</li>
      <li>Active Internal Bleeding</li>
      <li>Significant Facial Trauma w/i 3mo</li>
      <li>SK: Past Exposure w/i 6mo</li>
      <li>Severe HTN refractory to treatment</li>
    </ul>
  </li>
  <li>Relative CIs
    <ul>
      <li>Hx Poorly Controlled HTN</li>
      <li>Hx of Ischemic Stroke</li>
      <li>Traumatic or Prolonged CPR or Major Surgery (Surgery w/i 3wks)</li>
      <li>Internal Bleeding (&lt;2-4wks)</li>
      <li>Pregnancy</li>
      <li>Active Ulcers</li>
      <li>Current Anticoagulant Use</li>
      <li>&gt; 75yo</li>
    </ul>
  </li>
  <li>Monitoring
    <ul>
      <li>SSx of Reperfusion</li>
      <li>SSx of Bleeding</li>
      <li>CBC: Baseline and QD</li>
      <li>Plt: Baseline</li>
      <li>INR/aPTT: Baseline</li>
      <li>Mental Status Q2H</li>
    </ul>
  </li>
</ul>

<h4 id="antiplatelts">Antiplatelts</h4>

<ul>
  <li>ASA
    <ul>
      <li>325mg chewed and swallowed then 81mg QD forever</li>
    </ul>
  </li>
  <li>Clopidogrel
    <ul>
      <li>300mg loading dose then 75mg QD</li>
      <li>Minimum of 14d, up to 1yr</li>
      <li>D/C 5d before elective CABG</li>
      <li><strong>Do not load if &gt; 75yo</strong></li>
    </ul>
  </li>
</ul>

<h4 id="anticoagulation-1">Anticoagulation</h4>

<p>Give for at least 48hr, preferably 8d or duration of hospital stay</p>

<ul>
  <li>UFH
    <ul>
      <li>60 U/kg IVPB (Max 4000 U) the 12 U/kg/hr (Max 1000 U/hr)</li>
      <li>aPTT 50-70s (1.5-2x control)</li>
      <li>Not for more than 48hr</li>
      <li>Monitor SSx of Bleeding; Baseline and QD CBC; aPTT Baseline and q6h until stable then QD; Plt Baseline then q1-3d (preferably QD); Baseline INR</li>
    </ul>
  </li>
  <li>Enoxaparin
    <ul>
      <li>30mg IVPB and 1mg/kg SC Q12H (Usually max 100mg for first 2 doses)</li>
      <li>CrCl [10,30) 1mg/kg SC Q24H</li>
      <li>&gt; 75yo 0.75 mg/kg Q12H (Max of 75mg for first 2 doses)</li>
      <li>Monitor SSx of Bleeding; Baseline and QD SCr and CBC; Baseline Plt, aPTT, and INR (Plt only if UFH w/i ~3mo)</li>
    </ul>
  </li>
  <li>Fondaparinux
    <ul>
      <li>2.5mg IVPB then 2.5mg SC QD for up to 8d or until CABG or PCI</li>
      <li><strong>Caution if CrCl 30-50 mL/min</strong></li>
      <li><strong>CI if CrCl &lt; 30 mL/min</strong></li>
      <li>Monitor SSx of Bleeding; Baseline and QD CBC and SCr; Baseline aPTT, INR, and Plt</li>
    </ul>
  </li>
</ul>

<h2 id="secondary-prevention">Secondary Prevention</h2>

<ul>
  <li>
    <p>Non-ISA β-Blockers</p>

    <ul>
      <li>Metoprolol 25-50mg PO q6h or 5mg IVPB q5min x3 then PO</li>
      <li>Propranolol 40-80mg PO q6-8hr</li>
      <li>Atenolol 50-100mg PO QD or 5mg IVPB q5min x2 then PO</li>
      <li>Carvedilol 25-50mg PO BID</li>
      <li>Monitoring for PO: BP, HR, RR, 12 lead ECG, and SSx of HF q shift</li>
      <li>Monitoring for IV: BP, HR, RR, 12 lead ECG, and SSx of HF q5min</li>
    </ul>
  </li>
  <li>
    <p>RAAS Inhibitors</p>

    <table>
      <thead>
        <tr>
          <th>Drug</th>
          <th>Initial Dose</th>
          <th>Target Dose</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>Captopril</td>
          <td>6.25-12.5 mg</td>
          <td>50mg BID-TID</td>
        </tr>
        <tr>
          <td>Lisinopril</td>
          <td>2.5-5mg</td>
          <td>10-20mg QD</td>
        </tr>
        <tr>
          <td>Enalapril</td>
          <td>2.5-5mg</td>
          <td>10mg BID</td>
        </tr>
        <tr>
          <td>Ramipril</td>
          <td>1.25-2.5mg</td>
          <td>5mg BID or 10mg QD</td>
        </tr>
        <tr>
          <td>Trandolapril</td>
          <td>1mg</td>
          <td>4mg QD</td>
        </tr>
        <tr>
          <td>Candesartan</td>
          <td>4-8mg</td>
          <td>32mg QD</td>
        </tr>
        <tr>
          <td>Valsartan</td>
          <td>40mg</td>
          <td>160mg BID</td>
        </tr>
        <tr>
          <td>Losartan</td>
          <td>12.5-25mg</td>
          <td>150mg QD</td>
        </tr>
        <tr>
          <td>Eplerenone</td>
          <td>25mg</td>
          <td>50mg QD</td>
        </tr>
        <tr>
          <td>Spironolactone</td>
          <td>12.5mg</td>
          <td>25-50mg QD</td>
        </tr>
      </tbody>
    </table>

    <ul>
      <li>ACEIs to all pts w/ LVEF &lt; 40%, DM or CKD w/o hypotension</li>
      <li>ACEIs / ARBs CI in Pregnancy, BRAS, hypotension</li>
      <li>ACEIs CI in previous angioedema</li>
      <li>Start ACEI or ARB w/i 24hr w/ stable BP</li>
      <li><strong>Do not give IV ACEI w/i 24hr of MI</strong></li>
      <li>Aldosterone Antagonists should be considered in patients w/ LVEF &lt; 40% w/ HF SSx OR DM</li>
      <li>Aldosterone Antagonists should be started w/i 3-14d post MI</li>
      <li>Aldosterone Antagonists should not be used w/ SCr &gt; 2.5 in men or &gt; 2 in women (or CrCl &lt; 30 mL/min), or w/ [K] &gt; 5 or who are receiving a K sparing diuretic</li>
      <li>Aldosterone Antagonists do not require K supplementation if K &gt; 4</li>
    </ul>
  </li>
  <li>Appropriate Statin</li>
  <li>Magnesium if low (to prevent hypokalemia)</li>
  <li>Glycemic Control PRN</li>
  <li>DHP CCB if angina is refractory to NTG and β-blockers</li>
</ul>

<h1 id="nstemi">NSTEMI</h1>

<h2 id="ischemia-strategy-vs-early-invasive">Ischemia Strategy vs Early Invasive</h2>

<p>Medical therapy unless</p>

<ul>
  <li>Failure of medical therapy</li>
  <li>High TIMI risk</li>
  <li>Myocardial ischemia on non-invasive test</li>
  <li>Require diagnostic coronary angiography anyway</li>
</ul>

<h2 id="timi-risk-score-for-nste-acs">TIMI Risk Score for NSTE-ACS</h2>

<p>One point for each of the following:</p>

<ul>
  <li>Age ≥ 65</li>
  <li>≥ 3 risk factors
    <ul>
      <li>SSx of HF</li>
      <li>Low SBP</li>
      <li>Tachycardia</li>
      <li>Old Age</li>
      <li>Elevated SCr</li>
      <li>Arrest on Admission</li>
      <li>ST-Deviation</li>
      <li>Elevated Troponin</li>
    </ul>
  </li>
  <li>CAD</li>
  <li>≥ 2 episodes of chest pain in the last 24hr</li>
  <li>≥ 0.5mm ST-segment depression</li>
  <li>(+) Biochemical Markers</li>
</ul>

<p>Score Evaluation</p>

<ul>
  <li>0-2: Low risk (Can Treat Outpatient)</li>
  <li>3-4: Medium Risk (Treat Inpatient)</li>
  <li>5-7: High Risk (Treat Inpatient)</li>
</ul>

<p>Risk of Events:</p>

<ul>
  <li>0-1: 4.6%</li>
  <li>2: 8.3%</li>
  <li>3: 13.2%</li>
  <li>4: 19.9%</li>
  <li>5: 26.2%</li>
  <li>6-7: 40.9%</li>
</ul>

<h2 id="ischemia-guided-therapy">Ischemia Guided Therapy</h2>

<ol>
  <li>DAPT w/ ASA and Clopidogrel or Ticagrelor</li>
  <li>Anticoagulation w/ UFH, SC Enoxaparin, or SC Fondaparinux</li>
  <li>Secondary Prevention as w/ STEMI</li>
</ol>

<h3 id="dosing-2">Dosing</h3>

<ul>
  <li>UFH
    <ul>
      <li>Same as Fibrinolysis</li>
    </ul>
  </li>
  <li>Enoxaparin
    <ul>
      <li>1 mg/kg SC Q12H w/ typical dose adjustments</li>
    </ul>
  </li>
  <li>Fondaparinux
    <ul>
      <li>2.5mg SC QD for ups to 8d</li>
      <li>Avoid if CrCl &lt; 30 mL/min</li>
    </ul>
  </li>
</ul>

<h2 id="early-invasive-therapy">Early Invasive Therapy</h2>

<ol>
  <li>DAPT w/ ASA and Clopidogrel and Ticagrelor +/- GPIs</li>
  <li>Anticoagulation w/ UFH, SC Enoxaparin, SC Fondaparinux, or IV Bivalirudin</li>
  <li>Angiography determines PCI, CABG, or medical management</li>
</ol>

<h3 id="dosing-3">Dosing</h3>

<ul>
  <li>UFH
    <ul>
      <li>Same as for PCI</li>
    </ul>
  </li>
  <li>Enoxaparin
    <ul>
      <li>0.3 mg/kg IVPB if last dose was &gt; 8-12hr or if less than 2 doses have been received</li>
      <li>Treat for 24-48hr or until end of PCI</li>
    </ul>
  </li>
  <li>Bivalirudin
    <ul>
      <li>0.1 mg/kg IVPB followed by 0.25 mg/kg/hr</li>
      <li>For PCI second bolus of 0.5 mg/kg IVPB followed by 1.75 mg/kg/hr</li>
      <li>Reduce to 1 mg/kg/hr (CrCl &lt; 30 mL/min) or 1.4 mg/kg/hr (CrCl (30,60))</li>
      <li>Continue PRN after PCI at 0.25 mg/kg/hr</li>
    </ul>
  </li>
</ul>

<h1 id="guidelines">Guidelines</h1>

<ul>
  <li><a href="http://www.acc.org/clinical-topics/acute-coronary-syndromes#sort=%40fwhatstrendingscore86069%20descending&amp;tab=guidelines">ACS Guidelines (AHA / ACC)</a></li>
  <li><a href="http://www.onlinejacc.org/content/67/10/1235">PCI in STEMI</a></li>
  <li><a href="http://www.onlinejacc.org/content/61/4/e78">STEMI Management</a></li>
  <li><a href="http://circ.ahajournals.org/content/130/25/e344">NSTEMI Management</a></li>
  <li><a href="http://www.onlinejacc.org/content/68/10/1082">DAPT in ACS</a></li>
</ul>

  </div>

</div>

<div class="credits">
  <p>Author: Corbin Cox <br>
  Created: 2018-2-8 <br>
  Last Updated: 2018-2-21</p>
</div>

<footer class="footer menus">
  <nav>
    <div class="footerLinks">
      <a href="/peripheral_brain/home.html">Home</a>
      <a href="/peripheral_brain/index.html">Disclaimer</a>
      <a href="/peripheral_brain/disease_list_old.html">Archived Diseases</a>
    </div>
  </nav>
</footer>


</body>
</html>
